Yu Itoh
Akita, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Novel hypnotics use and hip fracture risk in middle-aged and older adults: A large, population-based cohort study in Japan.
Journal: PCN reports : psychiatry and clinical neurosciences
Published: March 13, 2025
Association between polypharmacy and the long-term prescription of hypnotics in Japan: a retrospective cross-sectional study.
Journal: Frontiers in psychiatry
Published: July 27, 2024
Effects of policy interventions on psychotropic polypharmacy in Japanese older adults.
Journal: Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society
Published: April 26, 2024
Treatment Failure and Long-Term Prescription Risk for Guideline-Recommended Hypnotics in Japan.
Journal: JAMA network open
Published: April 17, 2024
Association between benzodiazepine anxiolytic polypharmacy and concomitant psychotropic medications in Japan: a retrospective cross-sectional study.
Journal: Frontiers in psychiatry
Published: March 22, 2024
Successful Electroconvulsive Therapy for Tardive Dyskinesia and Tardive Dystonia Refractory to Valbenazine Treatment: A Case Report and Narrative Literature Review.
Journal: Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology
Published: March 05, 2024
Association between sleep state misperception and bedtime behavior in patients with chronic insomnia.
Journal: Scientific reports
Published: January 12, 2024
Exploratory Validation of Sleep-Tracking Devices in Patients with Psychiatric Disorders.
Journal: Nature and science of sleep
Published: January 05, 2023
Effects of Japanese policies and novel hypnotics on long-term prescriptions of hypnotics.
Journal: Psychiatry and clinical neurosciences
Published: September 01, 2022
Relationship among psychotic features, benzodiazepine receptor agonists, and rehospitalization in patients with electroconvulsive therapy-responsive major depressive disorder: A retrospective 2-year observational study.
Journal: Neuropsychopharmacology reports
Published: June 01, 2022
Last Updated: 09/26/2026